Use of NOS inhibitor to expand hematopoietic stem cells

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$192,938.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43HL077058-01
Agency Tracking Number:
HL077058
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
ARGINOX PHARMACEUTICALS, INC.
ARGINOX PHARMACEUTICALS, INC., 120 CONSTITUTION DR, STE B, MENLO PARK, CA, 94025
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 PETER Krasnov
 (650) 324-5150
Business Contact
 KENNETH DRAZAN
Phone: (650) 324-5150
Email: drazan@arginox.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Hematopoietic cell-supported therapy is employed for a broad spectrum of malignancies and hematological disease. However, the approach is limited by the availability of hematopoietic stem cells; thus, the possibilit

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government